Skip to the page

Data / Form D filings / Cellerate Technologies, LLC

Cellerate Technologies, LLC: Form D filing

Cellerate Technologies, LLC, a biotechnology company in Naples, FL, filed a Form D with the SEC in 2025. The latest, on September 24, 2025, reports $1 million sold of a $1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
780 FIFTH AVENUE SOUTH, SUITE 200, Naples, FL, 34102
Phone
(239) 261-9924
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Florida
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2088065

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 24, 2025New notice$1,000,000$1,000,0001Aug 29, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ronald McGlennenExecutive Officer, Director
George HoedemanExecutive Officer, Director

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Sep 22, 2025 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Cellerate Technologies, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.